These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 6321977

  • 1. Rat liver homogenate (S9)-mediated binding of benzo[alpha]pyrene to DNA in V79 cells, V79 cell nuclei and aqueous solution.
    Sebti SM, Baird WM.
    Mutat Res; 1984 Feb; 125(2):307-14. PubMed ID: 6321977
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Benzo[a]pyrene--DNA adduct formation in target cells in a cell-mediated mutation assay.
    Sebti SM, Baird WM, Knowles BB, Diamond L.
    Carcinogenesis; 1982 Feb; 3(11):1317-20. PubMed ID: 6817937
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A benzo[alpha]pyrene-7,8-dihydrodiol-9,10-epoxide is the major metabolite involved in the binding of benzo[alpha]pyrene to DNA in isolated viable rat hepatocytes.
    Ashurst SW, Cohen GM.
    Chem Biol Interact; 1980 Jan; 29(1):117-27. PubMed ID: 7356534
    [Abstract] [Full Text] [Related]

  • 6. Formation and removal of benzo[a]pyrene metabolites--DNA adducts in cultured normal human fibroblasts using a microsome-activating system.
    Kaneko M.
    Mutat Res; 1984 Jan; 131(3-4):157-61. PubMed ID: 6325902
    [Abstract] [Full Text] [Related]

  • 7. Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts.
    Shou M, Harvey RG, Penning TM.
    Carcinogenesis; 1993 Mar; 14(3):475-82. PubMed ID: 8384091
    [Abstract] [Full Text] [Related]

  • 8. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
    Luch A, Seidel A, Glatt H, Platt KL.
    Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
    [Abstract] [Full Text] [Related]

  • 9. Benzo(a)pyrene:DNA adduct formation in early-passage Wistar rat embryo cell cultures: evidence for multiple pathways of activation of benzo(a)pyrene.
    Pruess-Schwartz D, Baird WM.
    Cancer Res; 1986 Feb; 46(2):545-52. PubMed ID: 3940629
    [Abstract] [Full Text] [Related]

  • 10. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
    Luch A, Coffing SL, Tang YM, Schneider A, Soballa V, Greim H, Jefcoate CR, Seidel A, Greenlee WF, Baird WM, Doehmer J.
    Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
    [Abstract] [Full Text] [Related]

  • 11. The formation of benzo [a] pyrene - deoxyribonucleoside adducts in vivo and in vitro.
    Ashurst SW, Cohen GM.
    Carcinogenesis; 1982 Jun; 3(3):267-73. PubMed ID: 6282487
    [Abstract] [Full Text] [Related]

  • 12. Benzo[a]pyrene-DNA adduct formation in target and activator cells in a Wistar rat embryo cell-mediated V79 cell mutation assay.
    Sebti SM, Moynihan CG, Anderson JN, Baird WM.
    Carcinogenesis; 1985 Jul; 6(7):983-8. PubMed ID: 4017178
    [Abstract] [Full Text] [Related]

  • 13. Magnesium ions affect the quantitative but not the qualitative microsome mediated binding of benzo[alpha]-pyrene to DNA.
    Ashurst SW, Cohen GM.
    Chem Biol Interact; 1979 Dec; 28(2-3):279-89. PubMed ID: 549744
    [Abstract] [Full Text] [Related]

  • 14. Cell specific activation of benzo[a]pyrene by fibroblasts and hepatocytes.
    Jones CA, Santella RM, Huberman E, Selkirk JK, Grunberger D.
    Carcinogenesis; 1983 Nov; 4(11):1351-7. PubMed ID: 6315253
    [Abstract] [Full Text] [Related]

  • 15. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N, Padgett WT, Nelson GB, Lambert GR, Ross JA, Nesnow S.
    Anal Biochem; 2006 Aug 15; 355(2):213-23. PubMed ID: 16797471
    [Abstract] [Full Text] [Related]

  • 16. Analysis of benzo(a)pyrene:DNA adducts formed in cells in culture by immobilized boronate chromatography.
    Pruess-Schwartz D, Sebti SM, Gilham PT, Baird WM.
    Cancer Res; 1984 Sep 15; 44(9):4104-10. PubMed ID: 6331665
    [Abstract] [Full Text] [Related]

  • 17. Rat bladder cell-mediated mutagenesis od Chinese hamster V79 cells and metabolism of benzo[a]pyrene.
    Langenbach R, Malick L, Nesnow S.
    J Natl Cancer Inst; 1981 May 15; 66(5):913-7. PubMed ID: 6262559
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the mutagenicity of benzo[a]pyrene in the V79/HGPRT system by bioantioxidants.
    Paschin YuV, Bahitova LM.
    Mutat Res; 1984 Jul 15; 137(1):57-9. PubMed ID: 6087130
    [Abstract] [Full Text] [Related]

  • 19. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by aryl hydrocarbon hydroxylase inducers.
    Wilson AG, Kung HC, Boroujerd M, Anderson MW.
    Cancer Res; 1981 Sep 15; 41(9 Pt 1):3453-60. PubMed ID: 6266656
    [Abstract] [Full Text] [Related]

  • 20. Binding of benzo[a]pyrene to histones and altered affinity of modified histone 1 for deoxyribonucleic acid.
    Jenson JC, FitzGibbon J, Brennan LA, Litman GW.
    Biochemistry; 1982 Feb 16; 21(4):601-7. PubMed ID: 6280751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.